IMEXHS Radiology services (ASX: IME) has secured a new A$1.6 million, 3-year contract with the San Carlos Hospital Foundation in Bogota, with an expected Annual Recurring Revenue (ARR) of A$530,000. The San Carlos Hospital Foundation, established in 1948, offers high-complexity healthcare services, specializing in surgical specialties. IMEXHS will implement its cloud-based Enterprise Software at the foundation.
IMEXHS, an innovative provider of medical imaging software and radiology services across 18 countries, prides itself on its software as a service (SaaS) imaging solutions, which include a Picture Archiving and Communications System (PACS), a Radiology Information System (RIS), a Cardiology Information System (CIS), and an Anatomical Pathology Laboratory Information System (APLIS). Their solutions are cloud-based, vendor-neutral, and designed to enhance productivity and cost savings while improving patient outcomes. IMEXHS Co-Founder and CEO, Dr. Germán Arango, expressed his satisfaction with the partnership, emphasizing their leading medical imaging technology and highly skilled radiology professionals. This new collaboration is set to bolster IMEXHS's presence in the healthcare industry.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 20, 2024
Nov 20, 2024
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
